Physician profile
Laurence Gelstein
NPI 1346208378
$2,608.56
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,386 · 2020: $337 · 2021: $446 · 2022: $80.22 · 2023: $334 · 2024: $25.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $375.93 | 2019-2020 | |
| Boston Scientific Corporation | $340.74 | 2019-2023 | Rezum Generator |
| Astellas Pharma US INC | $318.77 | 2019-2021 | |
| Aytu Biopharma, INC. | $218.71 | 2019 | |
| Neotract INC. | $164.40 | 2019-2020 | |
| Allergan, INC. | $144.60 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $141.47 | 2023 | Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $125.53 | 2019-2021 | |
| Convatec INC. | $108.11 | 2019-2024 | |
| Abbvie INC. | $92.66 | 2019-2021 | |
| Janssen Biotech, INC. | $84.46 | 2019-2021 | |
| Antares Pharma, INC. | $80.73 | 2019-2021 | |
| Rochester Medical Corporation | $80.22 | 2022 | |
| Amgen INC. | $36.28 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $35.21 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $33.92 | 2021 | |
| Myovant Sciences INC. | $32.54 | 2021 | |
| Endo Pharmaceuticals INC. | $25.03 | 2020-2021 | |
| Clarus Therapeutics INC. | $23.08 | 2021 | |
| Dendreon Pharmaceuticals LLC | $22.93 | 2021 | |
| Travere Therapeutics, INC. | $22.58 | 2020 | |
| Dentsply Ih INC. | $21.67 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $18.36 | 2021 | |
| Ge Healthcare | $17.88 | 2019 | |
| Zyla Life Sciences, INC. | $17.00 | 2019 | |
| 180 Medical, INC. | $14.07 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Gelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.